Lessening Incontinence Through Low-impact Activity

Inclusion Criteria:

   - Women aged 50 years or older who report urinary incontinence starting at least 3
   months prior to screening

   - Self-report at least required frequency of urinary incontinence episodes on a
   screening 3-day voiding diary

   - Self-report urgency-predominant (i.e., at least half of incontinence episodes being
   urgency-type), stress-predominant (i.e., at least half of episodes being stress-type),
   or mixed-type (i.e., an equal number of stress- and urgency-type episodes)
   incontinence on the screening voiding diary

   - Willing to refrain from initiating medical treatments that may affect their
   incontinence or voiding pattern during the study intervention period

Exclusion Criteria:

   - Participation in formal or organized yoga classes or instruction within the past 3
   months; or any prior yoga therapy directed specifically at improving urinary
   incontinence or pelvic floor dysfunction

   - Participation in at least weekly organized physical conditioning classes or
   instruction in the past 3 months involving muscle stretching and strengthening
   exercises (not including aerobic classes that do not emphasize stretching or
   strengthening).

   - Currently pregnant (by self-report or screening urine pregnancy test), gave birth
   within the past 6 months, or planning pregnancy during the study period (approximately
   2 to 6 months)

   - Current urinary tract infection (screening dipstick urinalysis with leukocyte estrace,
   nitrites or blood) or a history or 3 or more urinary tract infections in the preceding
   year

   - Report history of neurologic conditions such as stroke, multiple sclerosis, spinal
   cord injury, or Parkinson's disease, or a lumbosacral spine condition associated with
   neurological symptoms

   - Unable to walk up a flight of stairs or at least 2 blocks on level ground without
   assistance (i.e., functional capacity < 4 METs)

   - Unable to get up from a supine to a standing position in 10 seconds or less and
   without assistance

   - Morbid obesity defined by a measured body mass index of >40 kg/m2 at the screening
   evaluation.

   - Report any history of prior anti-incontinence or urethral surgery (not including
   urethral dilation), pelvic cancer, or pelvic irradiation for any reason

   - Report use of bladder botox, electrostimulation, bladder training, or pelvic floor
   exercise training (with certified practitioners) in the past 3 months

   - Report other surgery to the pelvis (hysterectomy, oophorectomy, vaginal surgery,
   bladder surgery, colon surgery) within the past 3 months

   - Report use of medications with the potential to affect incontinence (anticholinergic
   bladder medications, tricyclic antidepressants, selective norepinephrine reuptake
   inhibitors, mirabegron, loop diuretics) within the past month

   - Report starting stopping, or changing the dose of a medication with the potential to
   affect anxiety or stress symptoms (i.e., selective serotonin reuptake inhibitors,
   anxiolytics/sedatives, antipsychotics) within the past 1 month, or plans to start,
   stop, or change to dose of such a medication during the study period

   - Report use of medical devices (i.e. pessary) for incontinence within the previous
   month (participants may stop use of device and re-present for study)

   - Report history of interstitial cystitis, fistula or hole in bladder or rectum, or
   birth defect leading to urine leakage

   - Report symptomatic pelvic organ prolapse (assessed using a standardized question,
   ""Have your pelvic organs (uterus, bladder, or rectum) been dropping out of your
   vagina causing a feeling of bulging, pressure, or protrusion or a sensation like your
   "insides are coming out"?")

   - Report history of vulvodynia, chronic pelvic pain, or pain when practicing pelvic
   floor exercises

   - Report conditions that, in the judgment of the investigators, render potential
   participants unlikely to follow the protocol, including plans to move, substance
   abuse, significant psychiatric problems, or dementia

   - Participation in another research study that involves investigational drugs or devices
   that could potentially confound the results of this study

   - Unable to understand study procedures, complete study interviews, or and provide
   informed consent in English